華盛國際控股(01323.HK)擬折讓約15.79%配售最多8.4億股
格隆匯10月6日丨華盛國際控股(01323.HK)公吿,於2023年10月6日,配售代理與公司訂立配售協議,公司擬配售最多8.4億股配售股份,佔現有已發行股份約20.00%;及經配發擴大後已發行股本約16.67%。每股配售股份0.016港元,配售價較於配售協議日期所報收市價0.019港元折讓約15.79%。
待配售事項完成後,預期配售事項最高所得款項總額及所得款項淨額將分別約為13.43百萬港元及13.12百萬港元。
公司擬將配售事項所得款項淨額用於償付集團未償還短期負債。倘集團銀行結餘及現金不足以償還該等短期負債,則集團可能進行進一步的集資活動來籌集額外資金。
董事認為,配售事項乃經股本市場籌集額外資金的良機,並將加強集團的財務狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.